Quantitative Systematic Strategies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,657
Closed -$268K 576
2019
Q3
$268K Buy
+3,657
New +$257K 0.06% 354
2017
Q4
Sell
-6,489
Closed -$236K 581
2017
Q3
$236K Buy
+6,489
New +$247K 0.06% 382
2016
Q4
Sell
-41,823
Closed -$1.66M 344
2016
Q3
$1.66M Buy
41,823
+16,254
+64% +$612K 0.61% 29
2016
Q2
$826K Buy
25,569
+16,575
+184% +$567K 0.39% 96
2016
Q1
$266K Sell
8,994
-2,661
-23% -$73.4K 0.1% 216
2015
Q4
$308K Sell
11,655
-45,933
-80% -$1.19M 0.08% 402
2015
Q3
$1.36M Buy
57,588
+28,434
+98% +$686K 0.67% 17
2015
Q2
$692K Buy
29,154
+13,080
+81% +$295K 0.15% 219
2015
Q1
$383K Buy
16,074
+6,534
+68% +$147K 0.1% 301
2014
Q4
$204K Buy
+9,540
New +$192K 0.08% 282
2014
Q2
Sell
-51,708
Closed -$613K 280
2014
Q1
$613K Buy
+51,708
New +$597K 0.5% 46

Other funds holding EW

Quantitative Systematic Strategies's EW Position: Q4 2019 in Review

Quantitative Systematic Strategies sold out of Edwards Lifesciences (EW) in Q4 2019, closing a stake of 3,657 shares — an estimated $268K sold.

Quantitative Systematic Strategies first reported a position in EW in Q1 2014 and held it in 11 quarters. The position peaked at $1.66M in Q3 2016. 1,093 funds tracked by Wall St. Rank hold EW as of Q4 2019.

  • Quantitative Systematic Strategies reported no remaining Edwards Lifesciences position as of Q4 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 3,657 Edwards Lifesciences shares in Q4 2019, an estimated $268K.
  • Quantitative Systematic Strategies first reported a position in Edwards Lifesciences in Q1 2014 and held it in 11 quarters.
  • Quantitative Systematic Strategies's Edwards Lifesciences position peaked at $1.66M in Q3 2016.
  • 1,093 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2019, filed 11 Feb 2020.